Pluripotent cells of embryonic origin proliferate at unusually rapid rates and have a characteristic cell cycle structure with truncated gap phases. To define the molecular basis for this we have characterized the cell cycle control of murine embryonic stem cells and early primitive ectoderm-like cells. These cells display precocious Cdk2, cyclin A and cyclin E kinase activities that are conspicuously cell cycle independent. Suppression of Cdk2 activity significantly decreased cycling times of pluripotent cells, indicating it to be rate-limiting for rapid cell division, although this had no impact on cell cycle structure and the establishment of extended gap phases. Cdc2-cyclin B was the only Cdk activity that was identified to be cell cycle regulated in pluripotent cells. Cell cycle regulation of cyclin B levels and Y 15 regulation of Cdc2 contribute to the temporal changes in Cdc2-cyclin B activity. E2F target genes are constitutively active throughout the cell cycle, reflecting the low activity of pocket proteins such as p107 and pRb and constitutive activity of pRb-kinases. These results show that rapid cell division cycles in primitive cells of embryonic origin are driven by extreme levels of Cdk activity that lack normal cell cycle periodicity.
Introduction
Pluripotent cells of the embryonic epiblast have the capacity to differentiate into any of the three germ layers (Gardner and Beddington, 1988) and are the progenitors of all adult cells. Besides having wide-range differentiation potential, pluripotent cells of late preimplantation and early post-implantation embryos have the capacity to proliferate at unusually rapid rates (Solter et al., 1971; Snow, 1977) . Between 4.5 -6.0 dpc (days post coitum), the embryonic epiblast expands from 20 -25 cells to around 660 cells (Snow, 1977; Hogan et al., 1994) , reflecting a generation time of approximately 10 h. Cell division rates in the embryonic epiblast are further accelerated between 6.5 dpc and 7.0 dpc coinciding with, or just preceding, gastrulation. During this period cell number increases to over 4000, with mean generation times estimated to be as short as 4.4 h (Power and Tam, 1993; Hogan et al., 1994) . Although the proliferative burst associated with this phase of development has been well documented, the molecular mechanisms underpinning this have not been previously addressed.
Murine embryonic stem (mES) cells are derived directly from the ICM of late pre-implantation embryos (Evans and Kaufman, 1981; Martin, 1981; Brook and Gardner, 1997) and have been used extensively as an in vitro model on which to study specific aspects of early embryonic development (Bradley et al., 1984; Pederson, 1994) . In the presence of IL-6 family members such as leukaemia inhibitory factor (LIF), mES cells can be maintained in culture indefinitely as a stem cell population that closely resemble the pluripotent cell population of the inner cell mass (ICM) of late pre-implantation embryos (Smith et al., 1988; Williams et al., 1988; Pease et al., 1990) . Throughout extended periods of passaging, mES cells retain their broad differentiation potential in vitro and when introduced back into blastocyst-stage embryos, can contribute to normal development of the entire embryo and to the germ line (Robertson et al., 1986; Thomas and Capecchi, 1987; Beddington and Robertson, 1989) . Murine ES cells have been used extensively to understand the biology of late pre-implantation and early post-implantation development, including events associated with the formation of the three embryonic germ layers (Doetschman et al., 1985; Smith, 1991) . In common with cells of the ICM, mES cells have unusually short generation times (Chisholm et al., 1985) and express marker genes such as Rex-1 and the general marker of pluripotency, Oct4 (Haub and Goldfarb, 1991; Rogers et al., 1991; Pelton et al., 1998) .
Although a useful model system for the study of pluripotency during late pre-implantation development, mES cells are not representative of all pluripotent cells in the pre-gastrula embryo. Several subpopulations of pluripotent cells in the murine embryo have been described (Gardner and Rossant, 1979; Gardner and Beddington, 1988) , generally being distinguished by their differentiation potential and gene expression profiles (Haub and Goldfarb, 1991; Rogers et al., 1991; Pelton et al., 1998) . Recently, an in vitro model for the early post-implantation stages of pluripotent cell development has been described (Rathjen et al., 1999) , involving the direct conversion of mES cells into a second pluripotent cell lineage (mEPL cells). Murine EPL cells closely resemble the pluripotent population of early primitive ectoderm in the early post-implantation embryo in terms of their gene expression profile and differentiation potential (Rathjen et al., 1999; Lake et al., 2000) . Moreover, mEPL cells also display robust Oct4 and alkaline phosphatase activity, but do not express classical ICM markers characteristic of mES cells such as Rex-1 and Gbx2. mEPL cells also express primitive ectoderm markers such as Fgf-5 (Haub and Goldfarb, 1991; Rathjen et al., 1999) and have a distinctive early primitive ectoderm differentiation capacity (Rathjen et al., 1999; Lake et al., 2000) .
Pluripotent cells in the rodent epiblast have a cell cycle structure lacking fully formed G1 and G2 gap phases, in which a high proportion of time (*50 -60%) is devoted to S phase (MacAulay et al., 1993; this study) . A similar cell cycle structure has been reported for other pluripotent cell populations including mES cells (Savatier et al., 1994) , murine embryonal carcinoma (mEC; Kranenburg et al., 1995; Mummery et al., 1987a,b) and embryonal germ cells (EGCs; Resnick et al., 1992) . This is reminiscent of the extremely rapid cell/nuclear division cycles associated with early embryonic development in lower vertebrates such as Xenopus (Murray and Kirschner, 1989) and Danio (Yarden and Geiger, 1996) or the fruit fly Drosophila (Edgar and Lehner, 1996) . In these situations rapid cell division is achieved by structuring the cell cycle so that it lacks gap phases and consists purely of alternating rounds of DNA replication (S phase) and chromosome segregation (M phase).
The molecular machinery that drives the cell cycle has been well documented and is fundamentally conserved from unicellular eukaryotes, such as yeast, to mammals (Nurse, 1990 (Nurse, , 2000 Murray and Hunt, 1993) . The core of this machinery is a family of cyclindependent protein kinases (Cdks) that consist of a catalytic component (the Cdk) and a regulatory subunit, known as a cyclin (Murray and Hunt, 1993) . Cdk-cyclin complexes become activated at precise points of the cell cycle through multiple levels of control including complex assembly, regulation of cyclin levels, post-translational modification of the Cdk subunit, Cdk complex localization and by modulation of Cdk inhibitor levels. Precise temporal control of these activities is crucial in establishing transitions from one cell cycle phase to the next and in ensuring that cell cycle events are maintained in the correct order. Uncoupling of Cdk activity from cell cycle progression frequently results in genomic instability and aneuploidy, uncoupling of chromosome replication from segregation or uncontrolled cell proliferation (Gray-Bablin et al., 1996; Mumberg et al., 1996; Haas et al., 1997; Nielsen et al., 1997; Spruck et al., 1999; Harwell et al., 2000) . In metazoans, more than one Cdk-cyclin complex is generally required for the transition from one phase to the next. For example, passage from G1 through to S phase normally requires Cdk4/6-cyclin D and Cdk2-cyclin E activities. Amongst the key targets for these Cdks are the family of 'pocket' proteins, of which the retinoblastoma tumour suppressor protein (pRb) is a member, which functions by repressing E2F-dependent transcription that is required for the G1-S transition.
Molecular mechanisms underpinning the unusual cell cycle structure and rapid division rates of pluripotent cells in vivo and in vitro have not been previously defined. Savatier et al. (1994) reported an absence of hypophosphorylated pRb in mES cells which led to the hypothesis that this is related to their rapid rate of cell division. mES cells have also been reported to lack cyclin D-associated kinase activity (Savatier et al., 1995) but the significance of this is not obvious as cyclin D activities are normally closely associated with pRb phosphorylation and active proliferation in most cells, particularly non-transformed cells (Sherr, 1993 (Sherr, , 1996 . Hence, with no further information, the mechanism by which rapid cell proliferation and unusual cell cycle structures are achieved in pluripotent cells is not immediately apparent. To address this issue, we have characterized the activity of Cdk-cyclin complexes in mES and mEPL cells and propose that pluripotent cells of embryonic origin have common features with respect to their cell cycle structure and mode of Cdk regulation. Our results show that control of cell proliferation in embryonically-derived pluripotent cells is fundamentally different from that in differentiated somatic cell lineages.
Results

Pluripotent cells have an unusual cell cycle structure and precocious Cdk activity
Pluripotent cells of the early mouse embryo and their in vitro counterparts cycle at unusually rapid rates ( Figure 1a ). To determine if rapidly cycling pluripotent cell populations have a similar cell cycle structure, we first compared flow cytometry profiles of PI-stained cells from the 6.25dpc embryo to that of mES cells. Primitive ectoderm from the epiblast of 30 6.25dpc embryos, were surgically dissected away from nonpluripotent cells of the embryo and after making a single cell suspension, fixed cells were stained with PI and analysed by flow cytometry (Figure 1a ). We observed a strong resemblance between the cell cycle structures of mES cells and embryonically-derived primitive ectoderm in which 52 and 54% of cells were in S phase, respectively ( Figure 1a ). Both pluripotent cell populations exhibited a relatively low proportion Total cell RNA (15 mg) was resolved on agarose-formaldehyde gels, blotted and probed with Rex-1, Fgf-5, Oct4 and GAPDHspecific probes. Transcript levels were quantitated by phosphorimaging and shown relative to levels of the GAPDH control. (d) mES, mEPL-d2, mEPL-d4 cells and MEFs were fixed, stained with propidium iodide and DNA content analysed by flow cytometry analysis. (e) Precocious histone H1 kinase activity associated with mES and mEPL cells. Histone H1 kinase activity was assayed in cyclin A, B, E and Cdk2 immunoprecipitates from mES, mEPL-d2, mEPL-d4 and MEF whole cell lysates (100 mg protein). Levels of cyclin A, cyclin B, cyclin E and Cdk2 were evaluated by immunoblot analysis of extracts (15 mg protein) prepared from mES, mEPL-d2 and mEPL-d4 cells. Lower panel; quantitation of histone H1 kinase activity from immunoprecipitates of cells in G1 when compared to NIH3T3 fibroblasts and MEFs. To further investigate the idea that this type of cell cycle structure was common to other pluripotent cell populations, we characterized the same in early primitive ectoderm-like (EPL) cells in vitro. mEPL cells were generated directly from mES cells after 2 -4 days culture in MedII conditioned medium and exhibit distinct changes in colony morphology ( Figure 1b ) and marker gene expression (Figure 1c ). These cells proceed to differentiate in vitro with characteristics similar to that of early primitive ectoderm (data not shown; Rathjen et al., 1999; Lake et al., 2000) . Flow cytometry analysis showed that the cell cycle structure of mEPL cells was similar to that of mES cells and pluripotent primitive ectoderm from the embryonic epiblast (Figure 1a,d) . All three pluripotent cell populations devote significant proportions of time to S phase and lack fully established gap phases. The mean generation time for D3 mES cells was 11.0 h ( Figure 1a ) and upon conversion to mEPL cells, this was reduced to 8.1 h. The generation time of primitive ectoderm from 6.25dpc embryos is approximately 9.1 h (Snow, 1977) . Similar cell cycle profiles and generation times were observed for other mouse ES lines (including E14, CGR8 and MBL5) and corresponding mEPL cells (data not shown).
Absence of cell cycle regulated Cdk2 activity in murine pluripotent cells
To address the underlying mechanisms behind rapid cell proliferation and the unusual cell cycle structure associated with pluripotent cells, we evaluated the activity of several Cdk-associated complexes in asynchronous cell populations. Cdk4,6-cyclin D activities were omitted from this analysis because it has been reported previously that mES cells lack these activities (Savatier et al., 1995) and embryos before 6.0dpc do not express significant levels of cyclin D1, cyclin D2 or cyclin D3 (Wianny et al., 1998) . Murine ES and EPL cells express the somatic cyclin A2 subtype (Sweeney et al., 1996) , but not the germ line-specific subtype cyclin A1. The predominant form of cyclin E is the E1 subtype (our unpublished data).
In comparison to a panel of mouse cell lines including MEFs, NIH3T3 and Balbc 3T3 fibroblast, mES and mEPL cells display vastly elevated histone H1 kinase activity associated with cyclin A, cyclin B, cyclin E and Cdk2 (Figure 1e and data not shown). Both cyclin A and cyclin E were expressed at levels well beyond that seen in other primary and transformed mouse cell lines that were assayed, including MEFs and NIH3T3 fibroblasts. In contrast, Cdk2 levels were comparable to several other cell lines that were evaluated (Figure 1e and data not shown).
We then asked if these Cdk activities were cell cycle regulated by assaying H1 kinase activity in immunoprecipitates from statically-arrested mES and mEPL cell extracts. Cdk2 activity remained relatively constant between asynchronous, aphidicolin-blocked (predominantly S phase) and nocodazole-blocked cell populations (G2/M; Figure 2 ). Similar assays that evaluated cyclin A and cyclin E-associated Cdk activity also showed little variation between statically-blocked cell populations. These observations are somewhat surprising given the changes in Cdk activities that typically occur during the mammalian cell cycle (Murray and Hunt, 1993) , such as in the case of NIH3T3 cells (Figure 2) . Levels of cyclin A and cyclin E showed only modest differences (2 -3-fold) in the static blocks whereas Cdk2 was constant (data not shown). In contrast, cyclin B-associated activity was significantly higher in nocadozole-blocked cells compared to aphidicolin-blocked cells and was the only cell cycle regulated cyclin-associated H1 kinase activity detected in mES and mEPL cells. To confirm that blocked cells retained their pluripotency, Oct4 and alkaline phosphatase status was confirmed and these cells were shown to be capable of in vitro differentiation that was indistinguishable to that of untreated cells (data not shown; see Figure 8 ). It should be noted that the flow cytometry profile for aphidicolin-treated pluripotent cells, which arrest with a high proportion of cells in S phase, is vastly different to that seen for aphidicolin-blocked NIH3T3 fibroblasts, which arrest with a 2N DNA content. This can be accounted for by differences in the respective cell cycle structures.
To confirm that Cdk2, cyclin E and cyclin A associated kinase activities are not subject to cell cycle control in mES cells, we employed a synchronization procedure to allow for the evaluation of events over a complete cell division cycle. Conventional synchrony methods were either ineffective or inappropriate for mES cells, in part because of their cell cycle structure, making it necessary to use a nocodazole-aphidicolin synchronization procedure. Cells were initially blocked in nocodazole, then released and trapped at G1/S in the presence of aphidicolin (see Materials and methods). This reproducibly yielded a population of cells (490%) arrested at the G1-S boundary that could be released into S phase for synchrony experiments (Figure 2b ). Because the cell cycle of mES cells has a high proportion of S phase cells and relatively few G1 and G2 cells (see Figure 1 ), it was difficult to follow cells throughout multiple cell cycles. However, the approach allows mES cell cultures to be reliably tracked as a synchronous population for approximately one complete cell division cycle.
Cdk2 protein levels in whole cell lysates showed no obvious periodicity over a complete cell cycle ( Figure  2c ,d) and its histone H1-associated kinase activity showed no obvious signs of periodic regulation ( Figure  2d ), consistent with the static block data shown in Figure 2a . Robust amounts of cyclin E and cyclin A protein were detected by immunoblot analysis at all stages of the cell cycle. Cyclin E levels were, however, modestly elevated (1.5 -2.0-fold) in S phase compared to G2/M and G1 cells (Figure 2c ). No cyclic changes in cyclin E or A activities were reproducibly observed in synchronization experiments (Figure 2c ), consistent with our earlier static block results. Cyclin B activity was evaluated in parallel but in contrast to Cdk2, cyclin E and cyclin A activity, was clearly cell cycledependent being most active late in the cell cycle, coinciding with G2/M phase (Figure 2c,d ). Increased cyclin B-associated kinase activity during G2/M was accompanied by accumulation of cyclin B protein during late-S through to -M phase. Levels of cyclin B collapsed upon re-entry into G1, paralleling the loss of cyclin B-H1 kinase activity (Figure 2c, d) . These data show that while Cdc2-cyclin B activity shows cell cycledependent periodicity, Cdk2 activity is constitutive and that this, in part at least, can be accounted for by elevated levels of cyclins A and E throughout the cell cycle.
Cdk2 complexes are regulated by inhibitory tyrosine phosphorylation
Because levels of cyclin regulatory subunits do not seem to be rate-limiting in determining Cdk2 activity in pluripotent cells, we asked if Cdk2 itself was subject to inhibitory tyrosine phosphorylation on Y 15 . The activation status of Cdk2 and its potential regulation by inhibitory tyrosine phosphorylation was evaluated by using an in vitro Cdc25-activation assay (Gabrielli et al., 1997) . This involved treating Cdk2 immunoprecipitates with recombinant Cdc25b, a protein phosphatase that activates Cdk2 through dephosphorylation of its regulatory Y 15 residue. The activity status of Cdk2 complexes in extracts prepared from asynchronous, aphidicolin and nocodazole-blocked cells were then assayed in a histone H1 kinase assay (see Figure 2a ). These assays show that Cdk2 activity could be activated approximately threefold when treated with Cdc25b, independent of cell cycle position ( Figure 3) . Hence, the pool of Cdk2-cyclin complex in mES cells is only partially active and subject to inhibitory tyrosine phosphorylation. Similar results were obtained when cyclin A-associated H1 kinase activities were Figure 2 Histone H1 kinase activity associated with Cdk2, cyclin A and cyclin E is cell cycle independent. (a) Cdk2, cyclin A, cyclin E and cyclin B were immunoprecipitated from statically-blocked mES, mEPL (day 4) lysates (100 mg protein) or NIH3T3 (400 mg protein) cell lysates and assayed for histone H1 kinase activity. Levels of input protein in each immunoprecipitation were shown to be equivalent by immunoblot analysis (15 mg input protein) of Cdk2 in each extract. Flow cytometry profiles of PI-stained cells are shown (bottom panel). Quantitation of histone H1 kinase activity is shown; black bars, asynchronous cells; grey bars, aphidicolin blocked cells and white bars, nocodazole blocked cells. (b) Synchronization of mES cells. mES cells were blocked and released as a synchronous population from a G1-S arrest into S phase. Cells were fixed, stained with PI and analysed for cell cycle position based on DNA content by flow cytometry at hourly intervals over a 14 h period. The front profile represents the nocodazole-blocked population (Noc) and the second (T=0) shows a G1-S population of cells released from this block into aphidicolin. Subsequent profiles represent the hourly intervals at which cells were sampled after release. (c) Immunoblot analysis of cyclin B, cyclin A, cyclin E and Cdk2 in extracts (15 mg protein) from the synchronization shown in (b). (d) Histone H1 kinase assays from Cdk2, cyclin A, cyclin E and cyclin B immunoprecipitates (100 mg protein). As a loading control (input protein) cell lysates (15 mg protein) used for immunoprecipitation were analysed by immunoblotting and probed with polyclonal antibodies raised against Cdk2 and cyclin A. (e) Quantitative analysis of histone H1 kinase activities from assays performed in (d). Relative levels of kinase activity were calculated after background subtraction from each lane and represent the average of two independent experiments Cell cycle control of pluripotent cells E Stead et al assayed (data not shown). These results are not significantly different to the fold-activation of Cdk2 in immunoprecipitates from asynchronous NIH3T3 extracts ( Figure 3 ). So far, we have described Cdc2-cyclin B as the only cell cycle regulated Cdk activity in pluripotent cells. Regulation of Cdc2 by inhibitory Y 15 phosphorylation of Cdc2 was evaluated by probing cell lysates with an anti-phospho-Y 15 antibody that recognizes only the inactive form of Cdc2. This analysis was performed alongside blots probed with a pan-specific antibody that recognizes all forms of Cdc2. Unlike the regulation of Cdk2 that was cell cycle-independent, phosphorylation of Cdc2 on Y 15 was elevated in S phase-enriched cell populations but low in mitoticallyarrested cells (Figure 4 ) when cyclin B-associated kinase activity was at its highest (see Figure 2) . Hence, Y 15 phosphorylation of Cdc2 is cell cycle-dependent in murine embryonic stem cells and conforms to the general mode of Cdc2 regulation seen in other mammalian cell types.
Another potential level of control by which Cdk2 can be regulated is through its assembly into complexes with p21 or p27 . To establish if these Cdk inhibitors (CdkIs) had a potential role in the regulation of Cdk2 activity in mES and mEPL cells, we evaluated their expression status by immunoblot analysis. p21 and p27 were detectable in NIH3T3 and early passage MEFs to varying extents, whereas p21 was absent and p27 was almost beyond the level of detection in mES and mEPL cell extracts ( Figure 5 ). Moreover, p21 and p27 could not be detected in Cdk2, cyclin E or cyclin A immunoprecipitates from mES and mEPL cell lysates but could be detected under similar conditions from differentiated mES cell lysates (data not shown). The potential role of p57 in these cells has not been investigated.
Cdk2 activity determines cell division rates but not cell cycle structure
Our data suggests that precocious Cdk2 activity in mES and mEPL cells may be a major factor in driving their rapid rate of cell division and in perhaps establishing their unique cell cycle structure. By suppressing Cdk2 activity, we predict that one possible outcome would be to slow the rate of cell division and to increase the relative proportion of time spent in G1, thus establishing a longer gap phase. To test this idea we used a Cdk2-specific inhibitor, Ro09-3033 (Dhingra et al., 1998; Figure 6a) , to determine the impact that Cdk2 inhibition has on cell division rates, pluripotency and cell cycle structure. Ro09-3033 is highly selective for Cdk2 (IC 50 20 nM; Table 1 ), it binds irreversibly to the ATP binding site of Cdk2 (Dhingra et al., 1998) and enforces a cell cycle arrest when used in the low micromolar range, in a manner consistent with it targeting Cdk2 in vivo (Figure 6b ). Further details regarding this inhibitor are available on request. In mES cells, Ro09-3033 at 2 mM was shown to inhibit immunoprecipitated Cdk2 and cyclin E kinase activities by 50 -60% under our standard assay conditions (Figure 7a ). At this concentration and up to 20 mM, Ro09-3033 had no reproducible effect on the activity of other Cdks immunoprecipitated from mES lysates, such as Cdc2-cyclin B (see Figure 7a and data not shown). Moreover, the inhibitor had no effect on the expression pattern of mES cell marker genes Rex-1 and Figure 3 Cdk2 can be activated by Cdc25b in a cell cycle-independent manner. Cdk2 was immunoprecipitated from cell lysates prepared from mES cells (async; asynchronous, aphid, aphidicolin block; nocod, nocodazole block) or asynchronous NIH3T3 cells (as shown in Figure 2a ). H1 kinase assays were performed in duplicate; one reaction with recombinant GST and one with recombinant GST-Cdc25b. After termination of reactions, H1 kinase activities were quantitated and shown as the fold activation of Cdk2 activity after treatment with Cdc25b. Data is shown as the standard deviation for three independent experiments. Flow cytometry profiles of PI stained cells are shown (bottom panel) Oct4 (Figure 7b ), indicating that during the period of inhibitor treatment (up to eight passages) these cells retained their pluripotent characteristics. The concentration of Ro09-3033 required to produce a uniform cell cycle arrest in mES cells, where the S phase compartment of cells was depleted, was 4fivefold higher than that required for most other cell types tested including Saos2 cells (20 mM, Figure 6b ), NIH3T3 fibroblasts and MEFs (data not shown), indicating that pluripotent cells are less responsive to this inhibitor. Similar observations were also made with the Cdk2/Cdc2 inhibitor, roscovitine (see below).
Generation times of mES cells in this experiment were 11 h for untreated and 18.3 h for inhibitor-treated cells. Although a 66% increase in cell cycle time was observed for inhibitor-treated cells this had no major effect on the cell cycle structure, indicating that the increase in cycling time was distributed over all phases. The percentage of cells that incorporated BrdU after a 24 h labelling period was 98 and 95% for untreated and treated mES cells, respectively, indicating that differences in generation times can not be accounted for by an increase in the proportion of non-cycling cells (data not shown). Moreover, under these conditions Ro09-3033 had no effect on cell viability as judged by PI exclusion and the absence of a sub-2n DNA content. Similar observations were also made for roscovitine which typically acts as a cell cycle specific inhibitor in the low micromolar range (20 -30 mM), resulting in the accumulation of cells at G1/S or G2/M (Meijer and Kim, 1997) . In mES cells, roscovitine had no effect on cell division times or cell cycle structure up to concentrations of 140 mM (data not shown). We suspect the lowered sensitivity of mES cells to roscovitine and Ro09-3033 may be associated with the precocious activity of Cdk2-cyclin A,E and Cdc2-cyclin B complexes in these cells (see Figure 1) . These results are consistent with the idea that high Cdk activity is a rate-limiting factor underpinning rapid cell division in pluripotent cells of embryonic origin, but this per se is not responsible for their unusual cell cycle structure.
E2F target genes are not cell cycle regulated in mES cells
Activation of E2F target genes is tightly linked to the temporal activation of G1 Cdk activities and together, are crucial in establishing the length of G1 before commitment to S phase (Dyson, 1998; Helin, 1998) . Because the periodic activation of these genes normally relies on the temporal activation of G1 Cdk activities, we reasoned that E2F target genes may not be subject to normal modes of cell cycle regulation under circumstances where cyclin D activities are absent (Savatier et al., 1995) and where Cdk2 activities are elevated throughout the cell cycle (this study). To determine if E2F target genes such as cyclin E, B-myb, RRMP2 and Cdc2 are cell cycle regulated, levels of these transcripts were assessed first, in statically blocked cells. This analysis showed that transcripts corresponding to these E2F target genes display no (Figure 8a,b) . To evaluate this question in greater detail, transcript levels were evaluated in synchronous cells (see Figure 2b) . These experiments confirmed the static block results by showing a complete absence of cell cycle dependent E2F target gene activity (Figure 8c,d ). Extreme activity of Cdk2, cyclin A and cyclin E throughout the cell cycle is likely to be functionally linked to the cell cycle-independent activity of E2F target genes. We expected that under such conditions, the ability of pocket proteins such as pRb and p107 to form higher-order complexes with E2Fs would be limited. This possibility was confirmed by band-shift analysis in which E2F4, the predominant form of E2F activity in mES cells (Humbert et al., 2000) , was almost exclusively in the free form. In contrast, E2F activity in NIH3T3 cell extracts was distributed between free and pocket protein bound forms (Figure 9a) . Only a minor component of the overall E2F binding activity was complexed with pocket proteins, which for mES and mEPL cells was exclusively p107. Recruitment of E2F4 and p107 was independent of cell cycle position as judged by band-shift analysis ( Figure 9b ).
Discussion
At the beginning of this study we set out to explain and understand in greater detail, the molecular mechanisms underpinning rapid cell division rates in pluripotent cells of embryonic origin. This followed work originally described over 30 years ago, documenting rapid rates of cell division in the murine embryonic epiblast, during late pre-implantation and early postimplantation stages of development (Solter et al., 1971; Snow, 1977; Power and Tam, 1993) . Direct biochemical and detailed molecular characterization of these cells in vivo is not generally feasible due to difficulties in obtaining sufficient cell numbers. To circumvent this problem, we chose to characterize pluripotent cell populations in vitro that represent two distinct stages of embryonic development. First, mES cells, represent- Figure 7 Cdk2 activity levels determine the rate of mES cell division but not cell cycle structure. (a) mES cells were grown for up to eight passages in the presence (+) or absence (7) of Ro09-3033 (2 mM). Cdk2, cyclin E and cyclin B-associated H1 kinase activities were assayed as described previously after immunoprecipitation from whole cell lysates (100 mg protein). Input loading control was determined by probing immunoblots (15 mg lysate protein) with a-Cdk2 and a-Oct4 polyclonal antibodies. Quantitation of H1 kinase activities are shown in the lower panel as the average of two independent experiments. (b) Northern blot analysis of Oct4, Rex-1 and GAPDH transcripts from mES cells grown with (+) or without (7) inhibitor (2 mM) for the number of passages indicated. RNA was resolved by agarose gel electrophoresis, blotted and hybridized with [ 32 P]Oct4, Rex-1 and GAPDH probes (15 mg total RNA per lane). Lanes designated +/7 were RNA samples from mES cells grown for either two or 12 passages with inhibitor followed by four passages in the absence of inhibitor. (c) After eight passages in the presence (+) or absence (7) of 2 mM Ro09-3033, mES and mEPL cells were fixed and stained with PI and analysed by flow cytometry. The mean generation time (two independent experiments) for mES cells over this period is indicated in addition to the percentage of cells in G1, S and G2/M phases. Generation times of mEPL cells were not determined in this experiment 
Conserved aspects of cell division cycle control in pluripotent cells
Pluripotent cells of the embryonic epiblast, mES and mEPL cells all have cell cycles that are predominantly devoted to S phase (this study). This is similar to what has been previously described for some embryonal carcinoma cells (Kranenburg et al., 1995; Mummery et al., 1987a,b) , embryonal germ cells (Resnick et al., 1992) and is consistent with the properties of pluripotent cells in pre-gastrula rat embryos (MacAuley et al., 1993) . Moreover, mES and mEPL cells cycle with kinetics comparable to their counterparts in the embryonic epiblast. All of these cell types have proven pluripotentiality, raising the possibility that a common mode of cell cycle control, quite distinct from that in other cell types, is common to pluripotent cells of embryonic origin. How this related to the rapid cell division cycles that occur during early embryonic development in lower vertebrates such as Xenopus and Danio or the fruit fly Drosophila, was not obvious at the beginning of this study (discussed below).
An unusual mode of Cdk regulation in pluripotent cells
In this study we show that murine ES cells use mechanisms to drive cell proliferation that are quite distinct from that in other mammalian cell types. Central to the mechanisms that underpin rapid cell division in these cells is the extreme activity of Cdk2, cyclin A and cyclin E complexes, all of which lack cell cycle-dependent periodicity. The only Cdk activity that Whole cell extract (15 mg protein) was included in band-shift assays with or without a-E2F4 antibody (2 mg), a-p107 antibody (2 mg) or non-specific IgG (NS; 2 mg). Positions of free E2F and E2F-pocket protein complexes are indicated together with the positions of super-shifted complexes. (b) E2F-p107 complexes are not cell cycle regulated. Band shift analysis using extracts from synchronous cells at different stages of the cell cycle (see Figure  2 ). G1 cells (0 h post-release), S phase (S; 4 h post-release), G2 (7 h post-release) and M phase (M; 9 h post-release). a-p107 antibody (2 mg) was added to reactions where indicated we identified to be under periodic control was the classical mitotic oscillator, Cdc2-cyclin B, but even this Cdk activity showed unusually high activity. Cdc2-cyclin B activity was regulated by cyclin B availability and by inhibitory phosphorylation of Cdc2 on Y 15 , consistent with the previously characterized regulation of MPF in non-mammalian vertebrates (Murray and Kirschner, 1989) .
The absence of cell cycle regulated Cdk2 activity can be explained, in part at least, by persistent levels of its two regulatory subunits, cyclin E and cyclin A. In differentiated cells, levels of both cyclins are restricted to specific stages of the cell cycle by transcriptional control and ubiquitin-mediated proteolysis. The absence of cyclin E and cyclin A periodicity is reminiscent of events in early development of lower vertebrates and flies where cyclin E and A levels do not oscillate more than 2 -3-fold prior to formation of the germ layers (Rempel et al., 1995) . Although we observed no evidence for temporal regulation of Cdk2 or cyclin A, cyclin E did undergo modest changes in protein levels but not activity. Improved methods of synchronization may improve the resolution of cell cycle regulated events in pluripotent cells enabling subtle changes in Cdk-cyclin activities to be detected.
The absolute levels of Cdk2, cyclin E and cyclin A activity in murine pluripotent cells is unprecedented and far exceeds that seen in any primary or transformed cell line that we have assayed, even in breast tumour lines where cyclin E activity is deregulated (Keyomarsi et al., 1995; Gray-Bablin et al., 1996) . Although Cdk-cyclin complexes are not quantitatively active in pluripotent cells, the only level of control shown to restrict Cdk2 activity was through Y 15 phosphorylation. Cdk inhibitors such as p21 and p27 do not appear to have a major role in determining Cdk2 activity. Pluripotent cells appear to be different from typical somatic cells as they lack cyclin D-associated activities (Savatier et al., 1995; Wianny et al., 1998) . This observation was initially difficult to reconcile as the cyclin D-pathway is an essential component of the machinery controlling passage through G1. High cyclin E activity in breast cancer lines, however, can completely substitute for cyclin D-associated Cdk activities (Gray-Bablin et al., 1996) , presumably by acting through normal Cdk-cyclin D targets such as the pocket proteins (Cheng et al., 1999; see below) . Moreover, cyclin E can rescue cyclin D1 deficiency in mice indicating some level of functional redundancy (Geng et al., 1999) . Pluripotent cells in the early embryo may therefore have a reduced requirement for cyclin D because of elevated cyclin E activity.
Can Cdk activities account for short gap phases in pluripotent cells?
The most obvious feature of the pluripotent cell cycle, apart from it being unusually rapid, is its short G1 phase. A contributing factor to this is likely to be the activity of cyclin E and perhaps cyclin A associated kinases. This is supported by a large body of evidence demonstrating cyclin E to be a rate-limiting factor for the G1 to S transition (Ohtsubo and Roberts, 1993; Knoblich et al., 1994; Resnitzky et al., 1994; Wimmel et al., 1994) . For example, ectopic expression of cyclin E prematurely advances entry into S phase by truncating the length of G1, consistent with the idea that the length of G1 is determined by the timing and/ or rate at which cyclin E activity is accumulated. Therefore, cells that exhibit constitutively active cyclin E kinase activity may not be subject to this ratelimiting step for G1-S progression. This would be consistent with our results in pluripotent cells where ectopic cyclin E activity is associated with a truncated G1 phase.
Progression from G2 through to M phase is normally dependent on the activation of Cdk2-cyclin A and then Cdc2-cyclin B (Guadagno and Newport, 1996) . Cdk2 and cyclin A kinase activities are constitutively active throughout the cell cycle in mES cells and hence, activation of these complexes is unlikely to be rate-limiting for progression through G2 phase and for the activation of Cdc2-cyclin B. Instead, our results suggest that cyclin B availability and inhibitory Y 15 phosphorylation of Cdc2 are likely to be the main determinants that control the timing of mitotic entry. These results are consistent with the observation that pluripotent cells have a relatively short G2 phase.
Based on the proportion of time devoted to S phase (*50%) and a cell cycle length of 11 -12 h, we estimate that mES cells spend 5.5 -6.0 h in S phase. Likewise, we estimate that mEPL cells spend approximately 4 -5 h in S phase. These replication times are similar to that typically seen for a wide range of cell lines indicating that acceleration through S phase is not a major determinant of rapid cell division in pluripotent cells. These observations initially suggested that truncation of gap phases was the most likely mechanism by which pluripotent cells shorten their cell cycle length.
Are division rates and cell cycle structure separable features of pluripotency?
If Cdk levels influence the overall rate of cell division in pluripotent cells, we would predict from the previous argument that Cdk activity impacts on the length of gap phases. To test this idea we used biochemical inhibitors to suppress Cdk activity, in preference to p21 or p27-mediated approaches that in mES cells are problematic (our unpublished data). Our results are surprising in this context because inhibition of Cdk2 activity caused a general slow down of the cell cycle that was not associated with a delay in any specific cell cycle phase or any increase in the relative amount of time devoted to gap phases. Hence, cell division rates and cell cycle structure do not appear to be coupled. This implies that Cdk2 may be playing a major role in driving not only the G1-S transition, consistent with reports in the literature, but also advancement through S phase and from G2 into M phase, as suggested by the work of Hu et al. (2001) . Although Cdk activity is clearly a major driver of rapid cell division in pluripotent cells, absolute levels of Cdk2 activity per se appear to have little impact on cell cycle structure but have a marked influence on cell division rates. It is likely that cell cycle regulation of Cdk activity will be part of the mechanism that is required for the establishment of a longer cell cycle with normal gap phases, perhaps in conjunction with lowered Cdk activity. Hence, Cdk activity levels drive the overall rate of division in a phase independent manner but, cell cycle dependent control of these Cdks is probably required to independently regulate the gap phases. Although our results show that mES cells retain markers for pluripotency, we can not formally rule out the possibility that their differentiation potential is more restricted after changes to their proliferative capacity. We believe this possibility is unlikely, however, as these markers are tightly associated with the pluripotent state.
Cdk regulation and its impact on E2F target genes
While pRb is expressed at similar levels in mES and MEFs, it is in an exclusively hyperphosphorylated form in mES cells (Savatier et al., 1994) , regardless of cell cycle position. Since pluripotent cells are reported to lack cyclin D activities (Savatier et al., 1995; Wianny et al., 1998) , the main pRb kinase activities in pluripotent cells are likely to be Cdk2-cyclin E and Cdk2-cyclin A. This would explain the constitutively hyperphosphorylated state of pRb in mES cells and is consistent with reports that cyclin E can act through pRb independently of cyclin D (Gray-Bablin et al., 1996; Cheng et al., 1999; Geng et al., 1999) . This scenario predicts that recruitment of pocket proteins into complexes with E2Fs would be severely limited in mES cells and is consistent with the results of ours and others (Humbert et al., 2000) that only a minor fraction of E2F4 is assembled into complexes with p107. The role of E2F4 as the predominant E2F is intriguing because its localization in the nucleus is generally restricted to early G1, as part of a complex with p107. We propose that because p107 is not effectively recruited into E2F complexes (Humbert et al., 2000;  this study) and because E2F4 lacks a cyclin A binding domain (Krek et al., 1994; Xu et al., 1994) , there is no mechanism by which to remove E2F4-DP complexes from E2F target genes in mES cells. This is consistent with our observations that E2F4 DNA binding activity is cell cycle independent and that E2F target genes are active throughout the cell cycle. There is no reason to suggest that E2F4 is nonfunctional in pluripotent cells although we cannot eliminate the possibility that these genes are regulated by E2F-independent mechanisms.
As mES cells do not appear to have an active pRbcyclin D pathway and because other Cdk activities associated with G1-S progression are ectopically active throughout the cell cycle, we propose that primitive embryonic cells lack the normal G1 checkpoint (i.e. Rpoint) that regulates the G1-S transition. These observations help explain the rapid proliferative rates of pluripotent stem cells and their ability to form aggressively growing tumours when placed in a heterologous environment. Presumably, as embryonic cells lose pluripotency and commit to one of the three germ lineages, these mechanisms are activated. This may coincide with the establishment of full gap phases, slowing down of cell proliferation and the establishment of cell cycle regulated Cdk activities. How this occurs is unclear and will be the subject of further investigation.
Materials and methods
Cell culture, synchronization, embryo dissection and flow cytometry D3 mES cells (Doetschman et al., 1985) were cultured in the absence of feeders on tissue culture grade plastic-ware precoated with 0.1% gelatin-phosphate buffered saline (PBS), as described previously (Rathjen et al., 1999) . ES cell culture medium consisted of Dulbecco's Modified Eagle Medium (DMEM, Gibco BRL) supplemented with 10% foetal calf serum (FCS, Commonwealth Serum Laboratories), 1 mM Lglutamine 0.1 mM 2-mercaptoethanol, 100 U/ml penicillin, 100 U/ml streptomycin and 1000 U/ml recombinant human LIF (ESGRO) at 378C under 10% CO 2 . mEPL cells were formed and maintained by culturing as described previously (Rathjen et al., 1999) in ES-media containing 50% conditioned media (MedII) supplemented with 1 mM L-glutamine, 0.1 mM 2-mercaptoethanol, 100 U/ml penicillin and 100 U/ ml streptomycin at a density of 2610 4 cells/cm 2 . mEPL cells were passaged every 48 h. MedII conditioned media was prepared from HepG2 cells (ATCC HB-8065) grown for 5 days in DMEM supplemented with 10% FCS, 40 mg/ml gentamycin and 1 mM L-glutamine, after being seeded at 5610 4 cells/cm 2 . Cell supernatants were collected, filter sterilized then stored at 48C for up to 2 weeks. NIH3T3 mouse fibroblast and early passage (passage 2 -3) mouse embryonic fibroblasts (MEFs), prepared from outcrossed Swiss mice (Robertson, 1987) , were cultured in DMEM supplemented with 10% foetal calf serum, 1 mM L-glutamine, 100 U/ml streptomycin and 100 U/ml penicillin. mES and mEPL cells were statically synchronized in prophase/mitosis by the addition of 45 ng/ml nocodazole (Sigma) to media for 12 h or, in G1-S/S phase by the addition of aphidicolin (Sigma) at 20 mg/ml for 12 h. NIH3T3 fibroblasts and MEFs were blocked by the addition of nocodazole and aphidicolin for 24 h at the same concentrations used for mES and mEPL cells. For synchronization experiments, cells were blocked with nocodazole at 45 ng/ml for 12 h after being plated for 48 h, washed four times in PBS and released into fresh pre-warmed media supplemented with 20 mg/ml aphidicolin for 10 h. The washing procedure was finally repeated allowing cells to be released into S phase as a synchronous population. Cells were harvested from petri dishes, after a 5 min incubation in TEN buffer (40 mM Tris pH 7.4, 1 mM EDTA and 150 mM NaCl), by scraping with a rubber policeman followed by two washes in PBS.
Time-mated 6.25dpc Swiss mouse embryos were dissected by first prizing open the mesometrial side of the decidua allowing the 'shelled' embryo to be released. After surgical removal of Reichardt's membrane and the extraembryonic region, visceral endoderm was peeled away from the epiblast by gently pipetting through a glass needle. Cells from pooled epiblasts were made into a single cell suspension by gentle pipetting in dispersal buffer (0.5% NP-40, 150 mM NaCl, 10 mM Tris-HCl pH 7.4, 2 mM CaCl 2 , 22 mM MgCl 2 ).
In preparation for flow cytometry, cells were resuspended in 300 ml of PBS supplemented with 1% FCS. Cells were then fixed by the drop-wise addition of 900 ml of ice cold 95% ethanol while vortexing and left on ice for 10 min. Cells were collected by centrifugation (3000 g, 5 min), washed twice in 700 ml of cold PBS before being finally resuspended in PBS. Cells were stained by the addition of 2.5 mg/ml propidium iodide (Sigma) and 0.5 mg/ml RNAase A and analysed on a Beckman-Coulter flow cytometer with WinMDi software.
Cell lysates, antibodies, immunoblot analysis and gel mobility shift assays Cells were washed once in TEN buffer then harvested by scraping from petri dishes using a rubber policeman, followed by two PBS washes. Cell pellets were collected by centrifugation in microfuge tubes (14 000 g, 1 min), washed twice in PBS, snap frozen and stored at 7808C. Whole-cell lysates were prepared by resuspending cell pellets at 10 7 cells/ ml in ice-cold lysis buffer (50 mM HEPES pH 7.9, 250 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 0.4 mM NaF, 0.4 mM NaVO 4 , 10% glycerol, 0.1% NP40, 0.5 nM PMSF, 1 mg/ml leupeptin, 1 mM DTT) for 1 h on ice with intermittent vortexing. Lysates were clarified by centrifugation at 14 000 g for 10 min at 48C and protein concentrations determined by Bradford assay using a BioRad kit. Cell lysates were either snap frozen and stored at 7808C or used immediately for immunoprecipitations.
Rabbit polyclonal antibodies raised against cyclin E (M-20), cyclin A (C-19), Cdk2 (M-2), cyclin B1 (H-433), E2F4 (C-20), p107 (SD-9X), p27 (C-19), Oct4 (N-19) were from Santa Cruz, anti-peptide polyclonal antibodies recognizing Cdc2 (#9112) and Y 15 phosphorylated Cdc2 (#9111) were from Cell Signalling Technology, p21 (HJ21) antibodies were from NeoMarkers. The mouse monoclonal raised against btubulin (YOL1/34) was from Sera Laboratories. All antibodies were used according to the manufacturer's specifications.
Cell lysates were resolved on 8 -12% SDS Tris-glycine or Tris-tricine polyacrylamide gels, electrotransferred to nitrocellulose membranes and blocked in PBS containing 0.1% Tween-20 (PBST) and 5% milk powder (Diploma) for at least 2 h. Membranes were incubated with primary antibody in PBST supplemented with 1% milk powder for a further 2 h, at room temperature or overnight at 48C. Membranes were then washed four times at room temperature for 15 min in PBST, then incubated for 1 h with HRP-conjugated donkey anti-rabbit or sheep anti-mouse secondary antibody (Dako; 1 : 2000) in PBST, 1% milk powder. HRP activity was detected with an ECL detection kit (Pierce) on Fuji X-ray film.
Gel mobility shift assays and extract preparation were performed as described previously (Ikeda et al., 1996) .
Immunoprecipitations, histone H1 kinase and Cdc25 activation assays
Protein A Sepharose (PAS) beads (Pharmacia) were stored in BSA (1 mg/ml), 0.05% sodium azide at 48C as a 50% slurry. All subsequent procedures were performed at 48C unless otherwise specified. Primary antibody was tumbled with PAS beads in lysis buffer for 2 h; 5 mg IgG was added per 30 ml of PAS beads. Cell lysate (1 mg/ml protein) in a total volume of 300 ml adjusted with lysis buffer, was pre-cleared with 30 ml PAS pre-incubated with 5 mg total rabbit IgG and tumbled for 30 min. PAS beads were removed by centrifugation (14 000 g, 10 s) and to the pre-cleared supernatant, 30 ml PAS beads loaded with primary antibody was added and tumbled for 2 h. PAS beads were collected by centrifugation (8000 g, 10 s), washed once with kinase lysis buffer (KLB; 50 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl 2 , 1 mM EGTA, 10 mg/ml leupeptin, 1 mM PMSF, 200 mM NaVO 4 , 10 mM NaPP, 100 mM NaF, 1 mM DTT), twice with KLB adjusted to 1 M NaCl, once with KLB, and three times with 50 mM HEPES pH 7.5, 1 mM DTT. Immune complexes were then resuspended in 20 ml of kinase buffer (50 mM HEPES pH 7.5, 10 mM MgCl 2 , 1 mM DTT, 2.5 mM EGTA, 0.1 mM NaVO 4 , 1 mM NaF) and 5 ml of master mix; 4 ml kinase buffer, 0.5 ml of histone H1 (Boehringer Mannheim) and 0.5 ml of [g-32 P]ATP (10 mCi/ ml) and incubated at 308C for 30 min. Kinase reactions were terminated by the addition of an equal volume of 26SDS load buffer (100 mM Tris-HCl pH 6.8, 20% glycerol, 4% SDS, 200 mM DTT). Phosphorylated histone H1 was resolved using a 12% SDS polyacrylamide gel. [
32 P]histone H1 was quantitated from dried gels using a phosphorimager (Molecular Dynamics).
The status of inhibitory Tyr 15 -phosphorylated forms of Cdk2 complexes in mES cell lysates were evaluated by their ability to be activated by recombinant GST-Cdc25b fusion protein as described previously (Gabrielli et al., 1997) . Cell extracts were prepared as described above but were supplemented with 0.1 mM sodium vanadate, 10 mM sodium fluoride, 2 mM microcystin and 20 mM cantharidin and washed finally in phosphatase buffer (20 mM Tris-HCl pH 8.3, 2 mM EDTA, 5 mM DTT 150 mM NaCl, 0.1% Triton X-100). Affinity purified GST-Cdc25b was eluted from glutathione-agarose with 10 mM reduced glutathione in phosphatases buffer supplemented with 0.1 mg/ml bovine serum albumin. Eluted GST-Cdc25b or GST alone was added to Cdk2 immunoprecipitates and incubated for 20 min at 308C. Reactions were terminated by addition of 5 ml of 5 mM sodium vanadate and the histone H1 kinase activity assayed as described above.
Protein kinase assays for the characterization of Ro09-3033 were performed as described in (Dhingra et al., 1998) . Recombinant human Cdc2-cyclin B, Cdk2-cyclin E and Cdk4-cyclin D, expressed from baculovirus expression constructs in insect cells, were kind gifts from Dr Wade Harper (Baylor College of Medicine, Houston, Texas).
Northern analysis
Cells were scraped from petri dishes following incubation for 5 min in TEN buffer at room temperature. Cells were washed twice and the pellet frozen at 7808C from which total RNA was extracted using the RNAzol kit (Tel-test). RNA (15 mg) was resolved on 1.5% agarose-formaldehyde gels, transferred to nitrocellulose membranes by capillary action and fixed to the membrane by UV-crosslinking (Stratalinker, Stratagene). Constructs used to generate cDNA fragments for the synthesis of probes for cyclin E, RRMP-2, Cdc2 and Bmyb have been described previously (Hurford et al., 1997) . Other probe DNA fragments used in this study were as follows; Oct4, (Scholer et al., 1990) ; Rex-1 (Hosler et al., 1989) ; Fgf-5 (Hebert et al., 1990) and mGAP (Rathjen et al., 1990) . [
32 P]probes were prepared using a Megaprime kit (Amersham) according to the manufacturer's instructions. Following pre-hybridization of filters for at least 2 h in UltraHyb (Amersham) at 428C, denatured probe was added directly to the pre-hybridization mix and allowed to hybridize for 15 -18 h. Membranes were washed twice for 20 min in 26SSC, 0.1% SDS at 428C and then twice for 20 min in 0.16SSC at 428C. Membranes were scanned and hybridization signals quantitated by scanning on a phosphorimager.
